Published in J Clin Psychiatry on August 01, 1997
Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety (2010) 1.07
Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image (2005) 1.05
The impact of gender on the assessment of body checking behavior. Body Image (2010) 0.81
Muscle dysmorphia: current insights. Psychol Res Behav Manag (2016) 0.77
Growing trends in the pursuit of muscularity: what healthcare professionals should be aware of. Br J Gen Pract (2015) 0.75
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability. Arch Gen Psychiatry (1992) 7.36
Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry (1993) 4.57
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med (2010) 4.33
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA (1999) 3.82
A current view of the interface between borderline personality disorder and depression. Am J Psychiatry (1991) 3.69
Recovered memories of childhood sexual abuse. BMJ (1998) 3.36
The Brown Assessment of Beliefs Scale: reliability and validity. Am J Psychiatry (1998) 3.26
Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts. J Acquir Immune Defic Syndr Hum Retrovirol (1996) 3.17
A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry (2000) 2.88
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania. Am J Psychiatry (1992) 2.70
Fluoxetine-induced akathisia: clinical and theoretical implications. J Clin Psychiatry (1989) 2.67
Affective spectrum disorder: does antidepressant response identify a family of disorders with a common pathophysiology? Am J Psychiatry (1990) 2.64
Standards for informed consent in recovered memory therapy. J Am Acad Psychiatry Law (2001) 2.60
Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol (2000) 2.34
Compulsive buying: a report of 20 cases. J Clin Psychiatry (1994) 2.29
Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. Circulation (2000) 2.09
The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA (1994) 2.08
Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther (2009) 1.99
Risk factors for neuroleptic malignant syndrome. A case-control study. Arch Gen Psychiatry (1989) 1.94
The Massachusetts General Hospital (MGH) Hairpulling Scale: 1. development and factor analyses. Psychother Psychosom (1995) 1.92
Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol (1989) 1.91
Self-injurious skin picking: clinical characteristics and comorbidity. J Clin Psychiatry (1999) 1.87
Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry (1996) 1.77
Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch Gen Psychiatry (1978) 1.72
The effect of risk factor reductions between 1981 and 1990 on coronary heart disease incidence, prevalence, mortality and cost. J Am Coll Cardiol (2001) 1.72
MDMA ("Ecstasy") abuse and high-risk sexual behaviors among 169 gay and bisexual men. Am J Psychiatry (2000) 1.66
Body image in boys: a review of the literature. Int J Eat Disord (2001) 1.63
Abstinence symptoms during withdrawal from chronic marijuana use. Exp Clin Psychopharmacol (2000) 1.61
Muscle dysmorphia: a new syndrome in weightlifters. Br J Sports Med (2002) 1.60
Muscle dysmorphia. An underrecognized form of body dysmorphic disorder. Psychosomatics (1998) 1.59
Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med (1992) 1.58
Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. J Clin Oncol (2005) 1.58
A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol Bull (1994) 1.58
Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry (1996) 1.56
Deciding where and how to be tested for HIV: what matters most? J Acquir Immune Defic Syndr (2001) 1.54
Obsessive compulsive spectrum disorder. J Clin Psychiatry (1994) 1.54
Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry (1986) 1.47
Personality disorders, history of trauma, and posttraumatic stress disorder in subjects with anxiety disorders. Compr Psychiatry (2001) 1.45
Valproate in the treatment of rapid-cycling bipolar disorder. J Clin Psychopharmacol (1988) 1.44
Are impulse-control disorders related to bipolar disorder? Compr Psychiatry (1996) 1.42
Canadian and American psychiatrists' attitudes toward dissociative disorders diagnoses. Can J Psychiatry (2001) 1.42
Rash complicating carbamazepine treatment. J Clin Psychopharmacol (1994) 1.42
Thirty-three cases of body dysmorphic disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry (1999) 1.40
A new identity for misidentification syndromes. Compr Psychiatry (1994) 1.39
Autoinduction of hypertensive reactions by tranylcypromine? J Clin Psychopharmacol (1989) 1.39
A screening questionnaire for body dysmorphic disorder in a cosmetic dermatologic surgery practice. Dermatol Surg (2001) 1.37
Repetitive skin-picking in a student population and comparison with a sample of self-injurious skin-pickers. Psychosomatics (2000) 1.32
Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc (2000) 1.30
Assessing the cost-effectiveness of pharmacogenomics. AAPS PharmSci (2000) 1.30
Evolution of the cerebellar cortex: the selective expansion of prefrontal-projecting cerebellar lobules. Neuroimage (2009) 1.28
Muscle dysmorphia in male weightlifters: a case-control study. Am J Psychiatry (2000) 1.27
Sensory phenomena in obsessive-compulsive disorder and Tourette's disorder. J Clin Psychiatry (2000) 1.22
Cultural expectations of muscularity in men: the evolution of playgirl centerfolds. Int J Eat Disord (2001) 1.21
Psychiatric and medical effects of anabolic-androgenic steroid use in women. Psychother Psychosom (2000) 1.20
Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug Alcohol Depend (1995) 1.19
Role of HIV counseling and testing in changing risk behavior in developing countries. AIDS (1995) 1.17
Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clin J Sport Med (1995) 1.17
Fibromyalgia and psychopathology: is fibromyalgia a form of "affective spectrum disorder"? J Rheumatol Suppl (1989) 1.15
Eating disorders in college men. Am J Psychiatry (1995) 1.15
Coronary angioplasty. Statewide experience in California. Circulation (1993) 1.15
Who seeks HIV testing? The impact of risk, knowledge, and state regulatory policy on the testing decision. Inquiry (1991) 1.15
Over-the-counter drug use in gymnasiums: an underrecognized substance abuse problem? Psychother Psychosom (2001) 1.15
Treatment of habit-tic deformity with fluoxetine. Arch Dermatol (1997) 1.13
The validity of DSM-III borderline personality disorder. A phenomenologic, family history, treatment response, and long-term follow-up study. Arch Gen Psychiatry (1983) 1.13
Hallucinogens on the Internet: a vast new source of underground drug information. Am J Psychiatry (2001) 1.11
Attributes of long-term heavy cannabis users: a case-control study. Psychol Med (2003) 1.11
A controlled study of lifetime prevalence of affective and other psychiatric disorders in bulimic outpatients. Am J Psychiatry (1987) 1.11
Insight and treatment outcome in obsessive-compulsive disorder. Compr Psychiatry (2001) 1.10
Lymphocytic-choriomeningitis-virus infection traced to a pet hamster. N Engl J Med (1974) 1.10
Body dysmorphic disorder: an obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? J Clin Psychiatry (1995) 1.09
Do patients use marijuana as an antidepressant? Depression (1996) 1.08
"Schizoaffective disorder": an invalid diagnosis? A comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry (1980) 1.08
Undiagnosed HIV infection in acute care hospitals. N Engl J Med (1992) 1.07
Factitious psychosis: phenomenology, family history, and long-term outcome of nine patients. Am J Psychiatry (1982) 1.07
Antidepressant drug therapy for bulimia: current status. J Clin Psychiatry (1986) 1.06
Near-fatal skin picking from delusional body dysmorphic disorder responsive to fluvoxamine. Psychosomatics (1999) 1.06
Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial. Am J Psychiatry (1998) 1.06
Pathological gambling and major affective disorder: preliminary findings. J Clin Psychiatry (1986) 1.05
Lycanthropy: alive and well in the twentieth century. Psychol Med (1988) 1.05
Changes in aggressive behavior during withdrawal from long-term marijuana use. Psychopharmacology (Berl) (1999) 1.05
Body dysmorphic disorder in men. BMJ (2001) 1.05
Family study of the aggregation of eating disorders and mood disorders. Psychol Med (2003) 1.05
Anorexia nervosa and bulimia among 300 suburban women shoppers. Am J Psychiatry (1984) 1.04
Phenomenological differences appearing with repetitive behaviours in obsessive-compulsive disorder and Gilles de la Tourette's syndrome. Br J Psychiatry (1997) 1.03
Kleptomania: a report of 20 cases. Am J Psychiatry (1991) 1.02
Bulimia treated with imipramine: a placebo-controlled, double-blind study. Am J Psychiatry (1983) 1.02
"Body image" drugs: a growing psychosomatic problem. Psychother Psychosom (2001) 1.01
Perceived stress in body dysmorphic disorder. J Nerv Ment Dis (1998) 0.99
Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study. Am J Psychiatry (1995) 0.98
Frequency and presentation of neuroleptic malignant syndrome: a prospective study. Am J Psychiatry (1987) 0.97
Tourette's disorder with and without obsessive-compulsive disorder in adults: are they different? J Nerv Ment Dis (1998) 0.97
Valproate in psychiatric disorders: literature review and clinical guidelines. J Clin Psychiatry (1989) 0.96
The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am (1996) 0.96
Familial hyperkalemic periodic paralysis and bipolar disorder: a linkage and treatment study. Biol Psychiatry (1984) 0.95
Fibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry (1985) 0.94
Fatal body dysmorphic disorder by proxy. J Clin Psychiatry (2001) 0.93
The relationship between fibromyalgia and major depressive disorder. Rheum Dis Clin North Am (1996) 0.93